Talk:Methohexital

Page contents not supported in other languages.
Source: Wikipedia, the free encyclopedia.
WikiProject iconPharmacology Mid‑importance
WikiProject iconThis article is within the scope of WikiProject Pharmacology, a collaborative effort to improve the coverage of Pharmacology on Wikipedia. If you would like to participate, please visit the project page, where you can join the discussion and see a list of open tasks.
MidThis article has been rated as Mid-importance on the project's importance scale.
WikiProject iconMedicine Mid‑importance
WikiProject iconThis article is within the scope of WikiProject Medicine, which recommends that medicine-related articles follow the Manual of Style for medicine-related articles and that biomedical information in any article use high-quality medical sources. Please visit the project page for details or ask questions at Wikipedia talk:WikiProject Medicine.
MidThis article has been rated as Mid-importance on the project's importance scale.

Untitled

The following information is from DrugBank, and should be rewritten (not copied!) into the article.

CITATIONS

This article does not cite any sources!!! —Preceding unsigned comment added by 71.204.15.239 (talk) 20:08, 2 May 2008 (UTC)[reply]

The statement that is it a barbiturate does not seem to need a source as the structure is given... —Preceding unsigned comment added by 92.234.76.73 (talk) 22:30, 28 February 2009 (UTC)[reply]

Pharmacology

Methohexital, a barbiturate, is used for the induction of anesthesia prior to the use of other general anesthetic agents and for induction of anesthesia for short surgical, diagnostic, or therapeutic procedures associated with minimal painful stimuli. Little analgesia is conferred by barbiturates; their use in the presence of pain may result in excitation.

Toxicity

The onset of toxicity following an overdose of intravenously administered methohexital will be within seconds of the infusion. If methohexital is administered rectally or is ingested, the onset of toxicity may be delayed. The manifestations of an ultrashort-acting barbiturate in overdose include central nervous system depression, respiratory depression, hypotension, loss of peripheral vascular resistance, and muscular hyperactivity ranging from twitching to convulsive-like movements. Other findings may include convulsions and allergic reactions. Following massive exposure to any barbiturate, pulmonary edema, circulatory collapse with loss of peripheral vascular tone, and cardiac arrest may occur.


Structure

I've removed File:Methohexital-3D-balls.png from the article, as the methyl group on nitrogen has been omitted by accident. The same problem affects File:Methohexital-3D-spacefill.png. The correct structure can be downloaded as a PDB file from my website: http://www.benjamin-mills.com/chemistry/structures/methohexital-from-xtal-2003.pdb. This is the structure of the SbRh stereoisomer as determined by X-ray crystallography and reported in Eur. J. Org. Chem. (2003) 5, 855–862. --Ben (talk) 22:03, 24 December 2011 (UTC)[reply]